Interleukin-6 blockade for severe COVID-19
Mathilde Roumier, Romain Paule, Matthieu Groh, Alexandre Vallée, Félix Ackermann, for the Foch COVID-19 Study Group
doi: https://doi.org/10.1101/2020.04.20.20061861
Mathilde Roumier
1Department of Internal Medicine, Hôpital Foch, F-92151 Suresnes, France
MDRomain Paule
1Department of Internal Medicine, Hôpital Foch, F-92151 Suresnes, France
MDMatthieu Groh
1Department of Internal Medicine, Hôpital Foch, F-92151 Suresnes, France
MDAlexandre Vallée
2Diagnosis and Therapeutic Center, Hypertension and Cardiovascular Prevention Unit, AP-HP, Hôtel-Dieu Hospital, Paris-Descartes University, Paris, France
MDFélix Ackermann
1Department of Internal Medicine, Hôpital Foch, F-92151 Suresnes, France
MDArticle usage
Posted April 22, 2020.
Interleukin-6 blockade for severe COVID-19
Mathilde Roumier, Romain Paule, Matthieu Groh, Alexandre Vallée, Félix Ackermann, for the Foch COVID-19 Study Group
medRxiv 2020.04.20.20061861; doi: https://doi.org/10.1101/2020.04.20.20061861
Subject Area
Subject Areas
- Addiction Medicine (322)
- Allergy and Immunology (625)
- Anesthesia (162)
- Cardiovascular Medicine (2338)
- Dermatology (205)
- Emergency Medicine (374)
- Epidemiology (11707)
- Forensic Medicine (10)
- Gastroenterology (693)
- Genetic and Genomic Medicine (3690)
- Geriatric Medicine (346)
- Health Economics (632)
- Health Informatics (2368)
- Health Policy (926)
- Hematology (340)
- HIV/AIDS (773)
- Medical Education (364)
- Medical Ethics (104)
- Nephrology (396)
- Neurology (3455)
- Nursing (195)
- Nutrition (520)
- Oncology (1804)
- Ophthalmology (533)
- Orthopedics (218)
- Otolaryngology (286)
- Pain Medicine (231)
- Palliative Medicine (66)
- Pathology (444)
- Pediatrics (1021)
- Primary Care Research (415)
- Public and Global Health (6092)
- Radiology and Imaging (1260)
- Respiratory Medicine (821)
- Rheumatology (375)
- Sports Medicine (320)
- Surgery (397)
- Toxicology (50)
- Transplantation (171)
- Urology (145)